We set out to identify and determine the diagnostic value of multiple blood-based biomarkers derived from patients who progress from pre-HF to either HFpEF or HFrEF, when combined with BNP measurements to establish novel panels of diagnostic and prognostic HF biomarkers. Here, NPPB is linked to hydrops fetalis.